LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

1. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. KEY INSIGHTS

2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES

2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS

2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENT

2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. TREATMENT OPTIONS

2.4.2. QUALITY OF MEDICAL PROCEDURES

2.4.3. PRICE OF TREATMENTS

2.4.4. SHIFT TOWARDS MEDICAL TOURISM

2.4.5. REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.6.1. RAW MATERIAL PROCUREMENT

2.6.2. MANUFACTURING

2.6.3. SUPPLY LOGISTICS

2.6.4. DISTRIBUTION CHANNELS

2.6.5. END-USERS

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS & PARTNERSHIPS

2.8.2. ACQUISITIONS & MERGERS

2.8.3. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS

2.9.2. RISING TREND IN DEPLAYED MARRIAGES AND PREGNANCIES

2.9.3. IMPROVEMENTS IN TREATMENTS

2.9.4. GOVERNMENT SUPPORT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST

2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY

2.10.3. RISKS ASSOCIATED WITH TREATMENTS

2.11. MARKET OPPORTUNITIES

2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY

2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING

3. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER

3.1. MALE

3.1.1. MALE INFERTILITY TESTING

3.1.1.1. DNA FRAGMENTATION

3.1.1.2. OXIDATIVE STRESS ANALYSIS

3.1.1.3. SPERM PENETRATION ASSAY

3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5. SPERM AGGLUTINATION

3.1.1.6. MICROSCOPIC EXAMINATION

3.1.1.7. OTHERS

3.1.2. MALE INFERTILITY TREATMENT

3.1.2.1. MEDICATION

3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY

3.2. FEMALE

3.2.1. FEMALE INFERTILITY TESTING

3.2.1.1. OVULATION TESTING

3.2.1.2. HYSTEROSALPINGOGRAPHY

3.2.1.3. LAPAROSCOPY

3.2.1.4. TRANSVAGINAL ULTRASOUND

3.2.1.5. OVARIAN RESERVE TESTING

3.2.1.6. HORMONAL LEVEL TESTING

3.2.1.7. OTHERS

3.2.2. FEMALE INFERTILITY TREATMENT

3.2.2.1. IVF WITH ICSI

3.2.2.2. IUI

3.2.2.3. IVF WITHOUT ICSI

3.2.2.4. SURROGACY

3.2.2.5. THERS

4. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER

4.1. FERTILITY AND SURGICAL CENTERS

4.2. HOSPITALS & RESEARCH LABORATORIES

4.3. CRYOBANKS

5. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK

5.1. BRAZIL

5.2. MEXICO

5.3. REST OF LATIN AMERICA

6. COMPETITIVE LANDSCAPE

6.1. ADORFEM

6.2. BANGKOK IVF CENTER

6.3. COOK MEDICAL INC

6.4. COOPER SURGICAL

6.5. CREATE FERTILITY CENTRE

6.6. EMD GROUP (MERCK KGAA)

6.7. ENDO INTERNATIONAL PLC

6.8. FERRING PHARMACEUTICALS

6.9. HALOTECH DNA

6.10. GENEA LTD

6.11. FUJIFILM IRVINE SCIENTIFIC

6.12. VITROLIFE AB

6.13. LABOTECT GMBH

6.14. OLYMPUS CORPORATION

6.15. PROGYNY

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

TABLE 1: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5: LIST OF ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES

TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 10: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 11: PROS AND CONS OF DNA SHARING METHODS

TABLE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 5: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %)

FIGURE 7: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 11: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 19: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 20: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 22: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)

FIGURE 23: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 25: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 26: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 27: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 28: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 29: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 30: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 31: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 32: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 33: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 34: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 35: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 36: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 37: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 38: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 39: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 40: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 41: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 42: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 43: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 44: BRAZIL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: MEXICO INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: REST OF LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)